ArticleNature cancer2023

Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.

Yan Mei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.